Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus
Hyperthermia treatment advances for brain tumors
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review
Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
L'analyse IOZK démontre la bonne tolérance de l'immunothérapie IOZK dans le gliome pontin intrinsèque diffus (DIPG)
Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
Dendritic Cells and Their Role in Immunotherapy
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience